FOSCX
Price
$34.41
Change
+$0.23 (+0.67%)
Updated
Jul 31 closing price
Net Assets
655.54M
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

FOSCX vs NAESX

FOSCX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
FOSCX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOSCX is a Buy and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. FOSCX (656M). NAESX pays higher dividends than FOSCX: NAESX (1.10) vs FOSCX (0.20). FOSCX was incepted earlier than NAESX: FOSCX (30 years) vs NAESX (66 years). FOSCX (1.37) is less costly to investors than NAESX (0.17). FOSCX is a more actively managed with annual turnover of: 31.00 vs. NAESX (17.00). NAESX has a lower initial minimum investment than FOSCX: NAESX (0) vs FOSCX (1000). NAESX annual gain was more profitable for investors over the last year : 22.56 vs. FOSCX (18.90). NAESX return over 5 years is better than : 34.95 vs. FOSCX (-2.73).
FOSCXNAESXFOSCX / NAESX
Total Expense Ratio1.180.17694%
Annual Report Gross Expense Ratio1.370.17806%
Fund Existence30 years66 years-
Gain YTD25.99814.563179%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets656M189B0%
Annual Yield % from dividends0.201.1018%
Returns for 1 year18.9022.5684%
Returns for 3 years16.4443.3038%
Returns for 5 years-2.7334.95-8%
Returns for 10 years40.26155.2826%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv